03/03/2021
7:42 PM | Aclaris Therapeutics (Issuer)
Gordon David N. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/03/2021
7:39 PM | Aclaris Therapeutics (Issuer)
Ali-Jackson Kamil (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/03/2021
7:36 PM | Aclaris Therapeutics (Issuer)
Ruffo Frank (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/03/2021
7:32 PM | Aclaris Therapeutics (Issuer)
Walker Neal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/25/2021
6:33 AM | Aclaris Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/25/2021
6:15 AM | Aclaris Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/11/2021
1:56 PM | Aclaris Therapeutics (Subject)
Foresite Capital Fund III, L.P. (Filed by)
| Form SC 13G/A
| |
02/11/2021
6:29 AM | Aclaris Therapeutics (Subject)
ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
| Form SC 13G/A
| |
02/10/2021
5:00 PM | Aclaris Therapeutics (Issuer)
Foresite Capital Fund III, L.P. (Reporting)
Foresite Capital Fund IV, L.P. (Reporting)
Foresite Capital Fund V, L.P. (Reporting)
Foresite Capital Management III, LLC (Reporting)
Foresite Capital Management IV, LLC (Reporting)
Foresite Capital Management V, LLC (Reporting)
Tananbaum James B. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
02/03/2021
4:33 PM | Aclaris Therapeutics (Issuer)
Mehra Anand (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
02/03/2021
4:29 PM | Aclaris Therapeutics (Issuer)
Ruffo Frank (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/03/2021
4:26 PM | Aclaris Therapeutics (Issuer)
Ali-Jackson Kamil (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/03/2021
4:23 PM | Aclaris Therapeutics (Issuer)
Walker Neal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2021
7:45 AM | Aclaris Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/20/2021
4:00 PM | Aclaris Therapeutics (Filer)
| Form 424B5
| |
01/20/2021
6:18 AM | Aclaris Therapeutics (Filer)
| Form S-3MEF
| |
01/19/2021
3:04 PM | Aclaris Therapeutics (Filer)
| Form 424B5
| |
12/17/2020
4:08 PM | Aclaris Therapeutics (Issuer)
Walker Neal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2020
4:07 PM | Aclaris Therapeutics (Issuer)
Ruffo Frank (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2020
4:06 PM | Aclaris Therapeutics (Issuer)
Ali-Jackson Kamil (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/15/2020
6:16 AM | Aclaris Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/04/2020
6:32 AM | Aclaris Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/04/2020
6:15 AM | Aclaris Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/26/2020
3:49 PM | Aclaris Therapeutics (Subject)
Aclaris Therapeutics (Subject)
Rock Springs Capital Management LP (Filed by)
| Form SC 13G
| |
09/15/2020
6:05 AM | Aclaris Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/03/2020
3:23 PM | Aclaris Therapeutics (Issuer)
Walker Neal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2020
4:18 PM | Aclaris Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/13/2020
4:28 PM | Aclaris Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/13/2020
4:26 PM | Aclaris Therapeutics (Filer)
| Form 424B5
| |
08/07/2020
6:31 AM | Aclaris Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/07/2020
6:16 AM | Aclaris Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/22/2020
2:04 PM | Aclaris Therapeutics (Subject)
MFN Partners Management, LP (Filed by)
| Form SC 13G/A
| |
07/07/2020
6:25 PM | Aclaris Therapeutics (Issuer)
Gordon David N. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2020
3:25 PM | Aclaris Therapeutics (Subject)
ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
| Form SC 13G
| |
06/24/2020
4:00 PM | Aclaris Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/17/2020
6:16 AM | Aclaris Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/08/2020
4:46 PM | Aclaris Therapeutics (Issuer)
Reasons Bryan M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/08/2020
4:45 PM | Aclaris Therapeutics (Issuer)
GOWEN MAXINE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/08/2020
4:31 PM | Aclaris Therapeutics (Issuer)
Molineaux Christopher P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/08/2020
4:30 PM | Aclaris Therapeutics (Issuer)
Mehra Anand (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/08/2020
4:29 PM | Aclaris Therapeutics (Issuer)
Humphries William D. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/08/2020
4:28 PM | Aclaris Therapeutics (Issuer)
Powell Andrew Kenneth William (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/08/2020
4:27 PM | Aclaris Therapeutics (Issuer)
SCHIFF ANDREW N (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/08/2020
4:24 PM | Aclaris Therapeutics (Issuer)
MILANO VINCENT (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2020
3:42 PM | Aclaris Therapeutics (Issuer)
Ali-Jackson Kamil (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/27/2020
6:03 AM | Aclaris Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/15/2020
6:04 AM | Aclaris Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/07/2020
3:31 PM | Aclaris Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/29/2020
11:15 PM | Aclaris Therapeutics (Filer)
| Form EFFECT
| |
04/23/2020
6:05 AM | Aclaris Therapeutics (Filer)
| Form DEFA14A
| |
04/23/2020
6:01 AM | Aclaris Therapeutics (Filer)
| Form DEF 14A
| |
04/07/2020
8:34 PM | Aclaris Therapeutics (Filer)
| Form D
Notice of Exempt Offering of Securities | |
03/31/2020
3:15 PM | Aclaris Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/13/2020
3:21 PM | Aclaris Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
02/25/2020
3:15 PM | Aclaris Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2020
12:49 PM | Aclaris Therapeutics (Subject)
Rock Springs Capital Management LP (Filed by)
| Form SC 13G/A
| |
02/13/2020
4:19 PM | Aclaris Therapeutics (Subject)
Broadfin Capital, LLC (Filed by)
| Form SC 13G/A
| |
02/13/2020
3:53 PM | Aclaris Therapeutics (Subject)
MFN Partners Management, LP (Filed by)
| Form SC 13G/A
| |
02/13/2020
11:36 AM | Aclaris Therapeutics (Subject)
Flynn James E (Filed by)
| Form SC 13G/A
| |
02/13/2020
9:38 AM | Aclaris Therapeutics (Subject)
MORGAN STANLEY (Filed by)
| Form SC 13G/A
| |
02/04/2020
6:13 PM | Aclaris Therapeutics (Issuer)
Walker Neal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/04/2020
6:12 PM | Aclaris Therapeutics (Issuer)
Ruffo Frank (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/04/2020
6:11 PM | Aclaris Therapeutics (Issuer)
Ali-Jackson Kamil (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/04/2020
1:25 PM | Aclaris Therapeutics (Subject)
FRANKLIN RESOURCES INC (Filed by)
| Form SC 13G/A
| |
01/13/2020
6:04 AM | Aclaris Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/09/2020
3:39 PM | Aclaris Therapeutics (Issuer)
MILANO VINCENT (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/09/2020
3:34 PM | Aclaris Therapeutics (Issuer)
MILANO VINCENT (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/08/2020
7:15 AM | Aclaris Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/20/2019
3:19 PM | Aclaris Therapeutics (Issuer)
Walker Neal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/19/2019
4:15 PM | Aclaris Therapeutics (Subject)
Arkin Moshe (Filed by)
| Form SC 13D/A
| |
12/18/2019
10:04 AM | Aclaris Therapeutics (Issuer)
Walker Neal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2019
10:02 AM | Aclaris Therapeutics (Issuer)
Ruffo Frank (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2019
10:00 AM | Aclaris Therapeutics (Issuer)
Ali-Jackson Kamil (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/21/2019
3:48 PM | Aclaris Therapeutics (Subject)
Arkin Moshe (Filed by)
| Form SC 13D/A
| |
11/21/2019
6:01 AM | Aclaris Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/07/2019
4:01 PM | Aclaris Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/07/2019
3:16 PM | Aclaris Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/31/2019
4:26 PM | Aclaris Therapeutics (Subject)
MFN Partners Management, LP (Filed by)
| Form SC 13G
| |
10/31/2019
3:18 PM | Aclaris Therapeutics (Issuer)
Gordon David N. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/16/2019
8:54 PM | Aclaris Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/15/2019
4:00 PM | Aclaris Therapeutics (Subject)
Arkin Moshe (Filed by)
| Form SC 13D
| |
10/10/2019
8:39 PM | Aclaris Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/27/2019
6:01 AM | Aclaris Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/09/2019
6:30 AM | Aclaris Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/05/2019
7:45 AM | Aclaris Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/29/2019
3:22 PM | Aclaris Therapeutics (Subject)
MORGAN STANLEY (Filed by)
| Form SC 13G
| |
08/08/2019
4:01 PM | Aclaris Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/08/2019
3:15 PM | Aclaris Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/31/2019
6:18 AM | Aclaris Therapeutics (Subject)
Flynn James E (Filed by)
| Form SC 13G/A
| |
07/30/2019
3:15 PM | Aclaris Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/29/2019
3:33 PM | Aclaris Therapeutics (Subject)
Rock Springs Capital Management LP (Filed by)
| Form SC 13G
| |
07/09/2019
4:11 PM | Aclaris Therapeutics (Subject)
Man Group plc (Filed by)
| Form SC 13G
| |
07/03/2019
3:47 PM | Aclaris Therapeutics (Issuer)
GOWEN MAXINE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2019
3:46 PM | Aclaris Therapeutics (Issuer)
GOWEN MAXINE (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/03/2019
3:44 PM | Aclaris Therapeutics (Issuer)
Gordon David N. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2019
3:15 PM | Aclaris Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/01/2019
4:01 PM | Aclaris Therapeutics (Issuer)
DEERFIELD MANAGEMENT COMPANY, L.P. (0001009258) (Reporting)
Deerfield Mgmt L.P. (Reporting)
DEERFIELD PARTNERS, L.P. (Reporting)
Deerfield Special Situations Fund, L.P. (Reporting)
Flynn James E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2019
4:52 PM | Aclaris Therapeutics (Issuer)
DEERFIELD MANAGEMENT COMPANY, L.P. (0001009258) (Reporting)
Deerfield Mgmt L.P. (Reporting)
DEERFIELD PARTNERS, L.P. (Reporting)
Deerfield Special Situations Fund, L.P. (Reporting)
Flynn James E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2019
5:31 PM | Aclaris Therapeutics (Issuer)
DEERFIELD MANAGEMENT COMPANY, L.P. (0001009258) (Reporting)
Deerfield Mgmt L.P. (Reporting)
DEERFIELD PARTNERS, L.P. (Reporting)
Deerfield Special Situations Fund, L.P. (Reporting)
Flynn James E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2019
5:15 AM | Aclaris Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
